Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Current assets:
Cash	$ 431,469	$ 551,272
Accounts receivable, net	120,355	117,512
Inventory	51,409	51,557
Prepaid expenses and other current assets	15,902	19,698
Total current assets	619,135	740,039
Property and equipment, net	47,702	46,332
Goodwill	283,535	152,766
Intangible assets, net	235,405	117,571
Deferred tax assets	793,210	808,117
Other assets	64,243	53,451
Total assets	2,043,230	1,918,276
Current liabilities:
Accounts payable	10,384	8,154
Accrued expenses and other current liabilities	32,411	34,574
Deferred revenue	3,693	10,211
Current portion of payable to related parties pursuant to a Tax Receivable Agreement	34,747	34,838
Current portion of long-term debt	5,440	6,000
Total current liabilities	86,675	93,777
Long-term debt, less current portion	524,499	524,591
Payable to related parties pursuant to a Tax Receivable Agreement, less current portion	711,232	713,481
Other long-term liabilities	66,522	41,066
Total liabilities	1,388,928	1,372,915
Stockholders' equity:
Additional paid-in capital	128,584	128,386
Retained earnings	251,423	184,561
Total stockholders' equity attributable to Maravai LifeSciences Holdings, Inc.	382,559	315,499
Non-controlling interest	271,743	229,862
Total stockholders' equity	654,302	545,361
Total liabilities and stockholders' equity	2,043,230	1,918,276
Class A Common Stock
Stockholders' equity:
Common stock	1,315	1,315
Class B Common Stock
Stockholders' equity:
Common stock	$ 1,237	$ 1,237